rs73373171
Positions:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_003803.4(MYOM1):c.2384+4A>T variant causes a splice donor region, intron change. The variant allele was found at a frequency of 0.000493 in 1,607,898 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0026 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00027 ( 1 hom. )
Consequence
MYOM1
NM_003803.4 splice_donor_region, intron
NM_003803.4 splice_donor_region, intron
Scores
2
Splicing: ADA: 0.7316
2
Clinical Significance
Conservation
PhyloP100: 4.43
Genes affected
MYOM1 (HGNC:7613): (myomesin 1) The giant protein titin, together with its associated proteins, interconnects the major structure of sarcomeres, the M bands and Z discs. The C-terminal end of the titin string extends into the M line, where it binds tightly to M-band constituents of apparent molecular masses of 190 kD (myomesin 1) and 165 kD (myomesin 2). This protein, myomesin 1, like myomesin 2, titin, and other myofibrillar proteins contains structural modules with strong homology to either fibronectin type III (motif I) or immunoglobulin C2 (motif II) domains. Myomesin 1 and myomesin 2 each have a unique N-terminal region followed by 12 modules of motif I or motif II, in the arrangement II-II-I-I-I-I-I-II-II-II-II-II. The two proteins share 50% sequence identity in this repeat-containing region. The head structure formed by these 2 proteins on one end of the titin string extends into the center of the M band. The integrating structure of the sarcomere arises from muscle-specific members of the superfamily of immunoglobulin-like proteins. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 18-3134646-T-A is Benign according to our data. Variant chr18-3134646-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 226812.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYOM1 | NM_003803.4 | c.2384+4A>T | splice_donor_region_variant, intron_variant | ENST00000356443.9 | NP_003794.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYOM1 | ENST00000356443.9 | c.2384+4A>T | splice_donor_region_variant, intron_variant | 1 | NM_003803.4 | ENSP00000348821 | P2 | |||
MYOM1 | ENST00000261606.11 | c.2384+4A>T | splice_donor_region_variant, intron_variant | 1 | ENSP00000261606 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00264 AC: 401AN: 152164Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
401
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000701 AC: 173AN: 246684Hom.: 1 AF XY: 0.000531 AC XY: 71AN XY: 133798
GnomAD3 exomes
AF:
AC:
173
AN:
246684
Hom.:
AF XY:
AC XY:
71
AN XY:
133798
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000269 AC: 391AN: 1455616Hom.: 1 Cov.: 31 AF XY: 0.000234 AC XY: 169AN XY: 723040
GnomAD4 exome
AF:
AC:
391
AN:
1455616
Hom.:
Cov.:
31
AF XY:
AC XY:
169
AN XY:
723040
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00264 AC: 402AN: 152282Hom.: 3 Cov.: 32 AF XY: 0.00267 AC XY: 199AN XY: 74442
GnomAD4 genome
AF:
AC:
402
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
199
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 10, 2015 | c.2384+4A>T in intron 16 of MYOM1: This variant is not expected to have clinical significance because it has been identified in 1.0% (98/9464) of African chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs73373171). - |
Uncertain significance, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Jan 07, 2013 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. Splice site variant (c.2384+4 A>T) in the MYOM1 gene Based on the information reviewed below, we categorize it as a VUS, probably benign due to its frequency in African Americans in population datasets. (Our patient is African American.) The c.2384+4 A>T variant is located in intron 16 of the MYOM1 gene, four nucleotides after exon 16. This variant was previously reported in the SNPDatabase as rs73373171. Based on data from the NHLBI Exome Sequencing Project (ESP), the T-allele has an overall frequency of approximately 0.23% (23/9,826), having been observed in 0.73% (23/3,154) of African American alleles, and in 0.0% (0/6,672) of European American alleles. Based on data from the 1000 Genomes Project, the A-allele has an overall frequency of approximately 0.23% (5/2,188). The highest observed frequency was 3 of 194 (1.55%) Luhya West African chromosomes studied. Based on nucleotide sequence alignment in 37 available vertebrate species, this nucleotide position is conserved in 35 of them. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to abolish the native donor splice site; however, direct evidence of the effect on splicing is unavailable. - |
MYOM1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 06, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Hypertrophic cardiomyopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2013 | Does not segregate with disease in family study (genes with incomplete penetrance);Subpopulation frequency in support of benign classification - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 4
Find out detailed SpliceAI scores and Pangolin per-transcript scores at